Skip to main content

Olaparib

Ovarian 1620
Ovarian Cancer Treatment

Update on PARP Inhibitors & Other Precision Cancer Medicines for Ovarian Cancer

By Dr. C.H. Weaver M.D.
Image placeholder title
Breast Cancer Treatment

PARP Inhibitors improve outcomes in BRCA mutated breast cancer. FDA approves Lynparza for treatment of TNBC and early stage breast cancer.

By Dr. C.H. Weaver M.D.
Prostate Cancer News & Updates
Prostate Cancer Treatment

PARP Inhibitors - Effective in Men with BRCA-Mutant Prostate Cancer

By Dr. C.H. Weaver M.D.
Image placeholder title
Ovarian Cancer Treatment

Lynparza Delays Progression & Significantly Prolongs Survival in Ovarian Cancer

By Dr. C.H. Weaver M.D.
Ovarian 1620
Ovarian Cancer Overviews

Treatment & Management of Ovarian Cancer

By Dr. C.H. Weaver M.D.
Image placeholder title
Ovarian Cancer Treatment

Rubraca Significantly Improves Ovarian Cancer Treatment

By Dr. C.H. Weaver M.D.